Position papers

Fair medicines prices are needed for European patients

The press regularly announces the discovery of a new drug or the purchase of promising small biotech companies for a substantial amount of money. But are the astronomical amounts that come along with......

04.12.2019 - Read more

We need more transparency on medicinal products markets!

Several World Health Organization Member States have tabled a Resolution on medicines transparency at the World Health Assembly. The International Association of Mutual Benefit Societies (AIM) has rea......

23.05.2019 - Read more

Medical Devices: Time to implement Regulations and increase Transparency

AIM, together with the European Association of Hospital Pharmacists (EAHP), the European Hospital and Healthcare Federation (HOPE), the European Social Insurance Platform (ESIP), Prescrire and the Sta......

26.02.2019 - Read more

AIM adopts Declaration on Health in all Policies

It is nowadays widely recognised that aspects of everyday life such as education, societal inclusion, housing standards, or meaningful employment, determine individuals’ health and wellbeing. Good h......

21.06.2018 - Read more

AIM agrees on position regarding the draft EC regulation on HTA and the Cabezón report

AIM supports the overall objective of the EC proposal on HTA and calls upon the Council of the European Union and the European Parliament to ensure a compromise text that will bring EU collaboration i......

11.06.2018 - Read more

The digital transformation must support solidarity-based healthcare systems

Please find AIM’s position on digital healthcare as a reply to the European Commission's Communication on Digital Healthcare transformation. Sustainable access to high quality healthcare systems......

03.05.2018 - Download
1 2 3 4 5